COVID-19 studies:  C19 studies: C19:  IvermectinIVM Vitamin DV.D HC QHC Q Vitamin CV.C ZincZn PVP-IPVP-I FLVFLV REGNR2 LY-CoVLY RemdesivirRMD
Global ivermectin adoption for COVID-19
Share  
Download Image
This is a draft showing the current status of ivermectin adoption around the world. Please send us corrections/updates with the form at the bottom of the page.
References
Argentina - mixed usage - Jan 26, 2021
Bangladesh - country-wide adoption
Belize - country-wide adoption - used for serious cases - Dec 18, 2020
Bolivia - country-wide adoption
Brazil - used in some regions - Jan 26, 2021
Bulgaria - country-wide adoption
Dominican Republic - country-wide adoption - Sep 30, 2020
Egypt - country-wide adoption - Nov 30, 2020
Guatemala - country-wide adoption - Jan 23, 2021
Honduras - country-wide adoption - 4/23/2020
India - used in many regions - used in many states
Iran - used in some regions - now manufacturing their own ivermectin, but the level of usage is unclear
Japan - used in some regions - Feb 13, 2021
Lebanon - country-wide adoption - Jan 27, 2021
Mexico - used in some regions - Dec 29, 2020
Nicaragua - country-wide adoption - Jan 25, 2021
North Macedonia - mixed usage - Jan 15, 2021
Panama - country-wide adoption
Peru - country-wide adoption - May 8, 2020
Slovakia - mixed usage - while approved, reports indicate only late treatment and limited availability - Jan 27, 2021
South Africa - used in some regions - practitioners must apply for approval to use - Jan 27, 2021
USA - used in some regions - Oct 31, 2020
Venezuela - country-wide adoption
Zimbabwe - country-wide adoption - Jan 28, 2021
Please send us corrections, updates, or comments.
Submit